Highbridge Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
LA
KC
MF
AA
WAM
MC
LP
TCM
AIMCA
PAMP
Highbridge Capital Management's TDAC Position: Q2 2026 in Review
Highbridge Capital Management increased its Translational Development Acquisition Corp (TDAC) stake by 2,130% in Q2 2026, buying an estimated $8.79M and bringing the position to 861,837 shares worth $9.21M. The position accounts for 0.22% of the portfolio, ranked #99.
Highbridge Capital Management first reported a position in TDAC in Q1 2026 and has held it in 2 quarters since. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.
- Highbridge Capital Management held 861,837 shares of Translational Development Acquisition Corp worth $9.21M as of Q2 2026.
- Highbridge Capital Management bought 823,198 Translational Development Acquisition Corp shares in Q2 2026, an estimated $8.79M.
- Translational Development Acquisition Corp made up 0.22% of Highbridge Capital Management's portfolio in Q2 2026, its #99 holding.
- Highbridge Capital Management first reported a position in Translational Development Acquisition Corp in Q1 2026 and has held it in 2 quarters since.
- 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.
Based on Highbridge Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.